Staged Low-Barrier and Mobile Care to Improve Retention and Viral Suppression in Hard-To-Reach Vulnerable People Living With HIV

分阶段进行低门槛和流动护理,以改善难以接触到的艾滋病毒感染者的保留和病毒抑制

基本信息

项目摘要

Project Summary/Abstract Existing HIV care systems in the United States, usually based on scheduled appointments, are often inadequate for people living with HIV who have significant psychosocial and structural barriers to engagement in care (i.e. homelessness/unstable housing, substance use disorders, severe mental illness). Rather than connect these individuals to an incompatible system of HIV care, new approaches are needed that reduce barriers to care engagement and offer increased flexibility. In this study, we seek to implement an evidence- informed multicomponent clinical intervention that includes drop-in (i.e. no appointments) multidisciplinary HIV primary care, mobile HIV care, staged escalation/de-escalation of care intensity as needed, and active referral of patients from community-based clinical and non-clinical sites into this care model. This clinical intervention will be implemented at four diverse care sites in San Francisco and Alameda counties, both priority jurisdictions in the U.S. Ending the HIV Epidemic (EHE) strategy: an academic safety net HIV clinic, a needle exchange program, and two federally qualified health centers. Eligibility criteria include: 1) current HIV viral load ≥200 copies/mL or off antiretroviral therapy, 2) history of poor HIV care engagement, and 3) homelessness/ unstable housing, any mental health disorder, or any illicit substance. We use the Consolidated Framework for Implementation Research (CFIR) and RE-AIM implementation frameworks to guide implementation strategy selection and our implementation and clinical effectiveness evaluation. In Aim 1, we will use implementation mapping to assess barriers and facilitators of implementation and convene key stakeholders to contextually integrate the clinical intervention and finalize the implementation strategies. In Aim 2, we will conduct a hybrid type 2 implementation-effectiveness study to evaluate the effect of clinical intervention implementation on co-primary outcomes of Reach (any HIV primary care visit) and Effectiveness (any HIV viral load <200 copies/mL) among patients referred to the care model over 12 months of follow-up (n=400), comparing outcomes to two propensity score matched control groups (400 contemporaneous controls identified using Department of Public Health data and 400 historical controls identified at study sites). We will also assess clinic-level implementation outcomes. In Aim 3, we will evaluate and model the individual, clinic, and population-level impacts of the intervention approach using heterogeneity and health equity analysis, cost/ cost-effectiveness analysis, scenario modeling of optimal and reduced component scenarios and population- level impact. Our multidisciplinary study team has a strong track record of implementation research to improve HIV care engagement among vulnerable populations. The proposed study will provide robust evidence for a drop-in/mobile HIV care approach and strategies to support implementation at a diverse set of clinic sites. By codifying these implementation strategies to facilitate wider-scale implementation, we seek to contribute to improving EHE Treatment outcomes among those for whom traditional models of care are sub-optimal.
项目总结/摘要 美国现有的艾滋病护理系统通常基于预约, 对于在参与方面存在重大心理和结构障碍的艾滋病毒感染者来说, (即无家可归/住房不稳定、药物使用障碍、严重精神疾病)。而不是 将这些人与不兼容的艾滋病毒护理系统联系起来,需要新的方法, 减少护理参与的障碍,并提高灵活性。在这项研究中,我们试图实现一个证据- 知情的多学科临床干预,包括直接(即无需预约)多学科艾滋病毒 初级保健、移动的艾滋病毒护理、根据需要分阶段提高/降低护理强度以及主动转诊 将社区临床和非临床站点的患者纳入这种护理模式。这种临床干预 将在旧金山弗朗西斯科和阿拉米达县的四个不同的护理点实施, 结束艾滋病毒流行(EHE)战略:一个学术安全网艾滋病毒诊所,一个针头 交换计划和两个联邦合格的健康中心。合格标准包括:1)目前的艾滋病毒 载量≥200拷贝/mL或停止抗逆转录病毒治疗,2)不良HIV护理参与史,以及3) 无家可归/不稳定的住房,任何精神健康障碍,或任何非法物质。我们利用联合 实施研究框架和RE-AIM实施框架, 实施策略的选择和我们的实施以及临床效果评价。目标1: 将使用执行情况摸底调查来评估执行的障碍和促进因素, 利益相关者根据具体情况整合临床干预并最终确定实施策略。在Aim中 2,我们将进行混合型2实施效果研究,以评估临床 干预措施在Reach(任何HIV初级保健就诊)和Effectiveness的共同主要结局上的实施 (any艾滋病毒载量<200拷贝/mL),在12个月的随访中, (n=400),将结果与两个倾向评分匹配的对照组(400个同期对照组)进行比较 使用公共卫生部数据和研究中心确定的400个历史对照确定)。我们将 还评估了临床层面的实施结果。在目标3中,我们将评估和建模个人,诊所, 使用异质性和健康公平性分析,成本/ 成本效益分析,最佳和减少组成部分的情景和人口的情景建模- 水平影响。我们的多学科研究团队在实施研究方面有着良好的记录, 在弱势群体中开展艾滋病毒护理工作。拟议的研究将提供有力的证据, 在不同的诊所实施的直接/移动的艾滋病毒护理方法和战略。通过 为了编纂这些执行战略,以促进更广泛的执行,我们力求促进 改善传统护理模式不理想的患者的EHE治疗结果。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Katerina A Christopoulos其他文献

Katerina A Christopoulos的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Katerina A Christopoulos', 18)}}的其他基金

Staged Low-Barrier and Mobile Care to Improve Retention and Viral Suppression in Hard-To-Reach Vulnerable People Living With HIV
分阶段进行低门槛和流动护理,以改善难以接触到的艾滋病毒感染者的保留和病毒抑制
  • 批准号:
    10462318
  • 财政年份:
    2022
  • 资助金额:
    $ 107.46万
  • 项目类别:
Mentoring Patient-Oriented Research on Advances to Optimize Engagement in HIV Care
指导以患者为中心的研究进展,以优化艾滋病毒护理参与
  • 批准号:
    10554007
  • 财政年份:
    2022
  • 资助金额:
    $ 107.46万
  • 项目类别:
Mentoring Patient-Oriented Research on Advances to Optimize Engagement in HIV Care
指导以患者为中心的研究进展,以优化艾滋病毒护理参与
  • 批准号:
    10678868
  • 财政年份:
    2022
  • 资助金额:
    $ 107.46万
  • 项目类别:
Understanding Patient, Provider, and Systems Stakeholder Attitudes and Preferences to Optimize Implementation of Long-Acting Injectable Antiretrovirals and Maximize Clinical and Public Health Impact
了解患者、提供者和系统利益相关者的态度和偏好,以优化长效注射抗逆转录病毒药物的实施并最大限度地提高临床和公共卫生影响
  • 批准号:
    10399428
  • 财政年份:
    2020
  • 资助金额:
    $ 107.46万
  • 项目类别:
Understanding Patient, Provider, and Systems Stakeholder Attitudes and Preferences to Optimize Implementation of Long-Acting Injectable Antiretrovirals and Maximize Clinical and Public Health Impact
了解患者、提供者和系统利益相关者的态度和偏好,以优化长效注射抗逆转录病毒药物的实施并最大限度地提高临床和公共卫生影响
  • 批准号:
    10022705
  • 财政年份:
    2020
  • 资助金额:
    $ 107.46万
  • 项目类别:
Understanding Patient, Provider, and Systems Stakeholder Attitudes and Preferences to Optimize Implementation of Long-Acting Injectable Antiretrovirals and Maximize Clinical and Public Health Impact
了解患者、提供者和系统利益相关者的态度和偏好,以优化长效注射抗逆转录病毒药物的实施并最大限度地提高临床和公共卫生影响
  • 批准号:
    10615725
  • 财政年份:
    2020
  • 资助金额:
    $ 107.46万
  • 项目类别:
Development and Validation of a Multidimensional Index of Engagement in HIV Care
艾滋病毒护理多维参与指数的制定和验证
  • 批准号:
    9067637
  • 财政年份:
    2013
  • 资助金额:
    $ 107.46万
  • 项目类别:
Development and Validation of a Multidimensional Index of Engagement in HIV Care
艾滋病毒护理多维参与指数的制定和验证
  • 批准号:
    8721488
  • 财政年份:
    2013
  • 资助金额:
    $ 107.46万
  • 项目类别:
Development and Validation of a Multidimensional Index of Engagement in HIV Care
艾滋病毒护理多维参与指数的制定和验证
  • 批准号:
    8606635
  • 财政年份:
    2013
  • 资助金额:
    $ 107.46万
  • 项目类别:
Development and Validation of a Multidimensional Index of Engagement in HIV Care
艾滋病毒护理多维参与指数的制定和验证
  • 批准号:
    9109456
  • 财政年份:
    2013
  • 资助金额:
    $ 107.46万
  • 项目类别:

相似海外基金

Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
  • 批准号:
    24K16436
  • 财政年份:
    2024
  • 资助金额:
    $ 107.46万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
  • 批准号:
    10093543
  • 财政年份:
    2024
  • 资助金额:
    $ 107.46万
  • 项目类别:
    Collaborative R&D
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 107.46万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 107.46万
  • 项目类别:
    EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
  • 批准号:
    24K20973
  • 财政年份:
    2024
  • 资助金额:
    $ 107.46万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 107.46万
  • 项目类别:
    EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
  • 批准号:
    481560
  • 财政年份:
    2023
  • 资助金额:
    $ 107.46万
  • 项目类别:
    Operating Grants
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
  • 批准号:
    10075502
  • 财政年份:
    2023
  • 资助金额:
    $ 107.46万
  • 项目类别:
    Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
  • 批准号:
    10089082
  • 财政年份:
    2023
  • 资助金额:
    $ 107.46万
  • 项目类别:
    EU-Funded
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
  • 批准号:
    2321091
  • 财政年份:
    2023
  • 资助金额:
    $ 107.46万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了